MarketOctodrine
Company Profile

Octodrine

Octodrine, also known as dimethylhexylamine (DMHA) and sold under the brand name Vaporpac among others, is a sympathomimetic and stimulant medication that was formerly used in the treatment of hypotension.

Side effects
Reported side effects of octodrine include hypertension, dyspnea, and hyperthermia. ==Pharmacology==
Pharmacology
It is described as a sympathomimetic, vasoconstrictor, and local anesthetic. ==Chemistry==
Chemistry
Related compoundsIsomethepteneMethylhexanamine (1,3-DMAA) • Tuaminoheptane1,3-Dimethylbutylamine (DMBA) • 1,4-Dimethylamylamine (1,4-DMAA) • Iproheptine (N-isopropyloctodrine) • Heptaminol (hydroxyoctodrine) • Oenethyl ==Society and culture==
Society and culture
Names Octodrine is the generic name of the drug and its and . It is also known by its former developmental code name SKF-51. As an unsafe dietary ingredient In the United States, DMHA is not eligible for use as a dietary ingredient, is not approved for use in manufactured foods or dietary supplements, and is not considered to be safe for human consumption (is not GRAS); in regarding DMHA as an unsafe food additive, the FDA has warned manufacturers that dietary supplements containing DMHA are adulterated and illegal for marketing. ==References==
tickerdossier.comtickerdossier.substack.com